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Coronary artery bypass graft (CABG) surgery may lead to postoperative complications
such as the acute kidney dysfunction (AKD), identified as any post-intervention increase
of serum creatinine level. Cardiovascular control reflexes like the baroreflex can play
a role in the AKD development. The aim of this study is to test whether baroreflex
sensitivity (BRS) estimates derived from non-causal and causal approaches applied to
spontaneous systolic arterial pressure (SAP) and heart period (HP) fluctuations can help
in identifying subjects at risk of developing AKD after CABG and which BRS estimates
provide the best performance. Electrocardiogram and invasive arterial pressure were
acquired from 129 subjects (67 ± 10 years, 112 males) before (PRE) and after (POST)
general anesthesia induction with propofol and remifentanil. Subjects were divided into
AKDs (n = 29) or no AKDs (noAKDs, n = 100) according to the AKD development
after CABG. The non-causal approach assesses the transfer function from the HP-
SAP cross-spectrum in the low frequency (LF, 0.04–0.15 Hz) band. BRS was estimated
according to three strategies: (i) sampling of the transfer function gain at the maximum
of the HP-SAP squared coherence in the LF band; (ii) averaging of the transfer function
gain in the LF band; (iii) sampling of the transfer function gain at the weighted central
frequency of the spectral components of the SAP series dropping in the LF band. The
causal approach separated the two arms of cardiovascular control (i.e., from SAP to
HP and vice versa) and accounted for the confounding influences of respiration via
system identification and modeling techniques. The causal approach provided a direct
estimate of the gain from SAP to HP by observing the HP response to a simulated
SAP rise from the identified model structure. Results show that BRS was significantly
lower in AKDs than noAKDs during POST regardless of the strategy adopted for its
computation. Moreover, all the BRS estimates during POST remained associated with
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AKD even after correction for demographic and clinical factors. Non-causal and causal
BRS estimates exhibited similar performances. Baroreflex impairment is associated with
post-CABG AKD and both non-causal and causal methods can be exploited to improve
risk stratification of AKD after CABG.
Keywords: heart rate variability, arterial pressure, autonomic nervous system, cardiovascular control, adverse
outcome, intensive care unit, cardiac surgery, propofol anesthesia
INTRODUCTION
Cardiac baroreflex (BR) is a regulatory mechanism aiming at
maintaining the physiological homeostasis by adjusting heart
period (HP) in response to arterial pressure (AP) variations
(Smyth et al., 1969; Laude et al., 2004). The efficiency of this
reflex is generally assessed by computing the baroreflex sensitivity
(BRS), quantifying the magnitude of HP changes following a unit
variation of AP (Vanoli and Adamson, 1994; Pinna et al., 2015).
The gold standard strategy to characterize BR is the invasive
pharmacological method (Smyth et al., 1969) that evaluates the
slope of the response of HP to a pharmacologically induced
increase or decrease in systolic AP (SAP), referred to as BR
sensitivity (BRS). Non-invasive strategies to assess BRS exist and
are based on the analysis of the spontaneous variability of HP
and SAP in time domain (Bertinieri et al., 1985; Westerhof et al.,
2004; Bauer et al., 2010; Muller et al., 2012; De Maria et al.,
2018), or frequency domain (Robbe et al., 1987; Pagani et al.,
1988; Saul et al., 1991; Porta et al., 2000, 2013; Faes et al., 2004;
Pinna et al., 2017) or using identification procedures estimating
parameters of mathematical models (Baselli et al., 1994; Patton
et al., 1995; Porta et al., 2000; Nollo et al., 2001; Xiao et al., 2005;
Porta et al., 2013).
Among the different methodologies to assess BRS, the non-
causal method in the frequency domain has been the most
frequently exploited one (Robbe et al., 1987; Pagani et al., 1988;
Saul et al., 1991; Porta et al., 2000, 2013; Faes et al., 2004; Pinna
et al., 2017). The non-causal approach in the frequency domain
is grounded on the computation of the cross-spectrum between
the HP and SAP variability series and on the estimation of the
transfer function directly from it. Then, once obtained the HP-
SAP transfer function, a strategy is needed to convert the gain
function into a single number representing the BRS. Non-causal
frequency domain BRS markers are mostly assessed in the low
frequency (LF, from 0.04 to 0.15 Hz) because in this band the
prerequisites for their safe computation, namely the high HP-SAP
association and HP variations lagging behind SAP ones are more
likely to be fulfilled (de Boer et al., 1985). Moreover, the baroreflex
origin of the LF oscillations detected in HP series has been
repeatedly suggested as a consequence of resonance properties of
baroreflex control loop and/or the latency of the baroreflex circuit
(De Boer et al., 1987; Baselli et al., 1994; Goldstein et al., 2011).
Baroreflex sensitivity estimates derived from the causal closed
loop approach (Baselli et al., 1994; Xiao et al., 2005; Porta
et al., 2013) have recently gained attention. The main features
of this class of BRS markers is that directionality of the HP-SAP
dynamical interactions and their closed loop nature are explicitly
accounted by the model structure underlying their computation.
Since the two characteristics are neglected by more traditional
non-causal frequency domain approaches, causal closed loop BRS
markers might have additional advantage in clinical applications.
Moreover, the additional advantage of the causal closed loop
BRS estimates is the possibility of accounting for the presence
of confounding factors, such as respiration (RESP) (Porta et al.,
2012), contaminating both HP and SAP variability.
The impairment of BR has a clinical value given that low BRS
values are associated to adverse outcome in several pathological
conditions. As a matter of fact, low BRS has a remarkable
predictive power of adverse events in chronic heart failure
(Gouveia et al., 2015; Pinna et al., 2017), myocardial infarction
(Landolina et al., 1997; La Rovere et al., 1998; De Ferrari et al.,
2007), diabetes (Gerritsen et al., 2001) and hypertension (Collier
et al., 2001; Gerritsen et al., 2001). More recently, BRS estimates
have been found to be useful in stratifying the risk of adverse
events and morbidity after major surgery (Toner et al., 2016;
Ranucci et al., 2017) and the inability to cope with increased
SAP variability has been correlated with a greater risk in critical
care unit (ICU) (Porta et al., 2018). Acute kidney dysfunction
(AKD) is one of the major complications after coronary artery
bypass graft (CABG) surgery (Ranucci et al., 2017). Since AKD
increases early and long-term mortality (Liotta et al., 2014) and it
is associated to cardiovascular complications such as heart failure
(Holzmann et al., 2013), the prevention of AKD after CABG
would improve the patient’s prognosis. Moreover, it would reduce
patient’s ICU stay and, consequently, hospitalization costs.
The use of BRS markers in predicting AKD after CABG
requires the optimization of the technique for the computation
of BRS. Indeed, the perioperative evaluation of BRS in patients
undergoing CABG is a challenging issue because they usually
feature an impaired BR regulation and the concomitant presence
of pharmacological therapy (Porta et al., 2013; Bari et al., 2018).
Therefore, the aim of this work is to check the performance of
non-causal and causal strategies for the BRS quantification in
differentiating patients who developed AKD after CABG from
the ones who did not (noAKD). We consider three non-causal
strategies to compute BRS based on cross-spectrum estimation
from spontaneous HP and SAP variability: (i) sampling the
transfer function gain at the maximum of the squared coherence
function (K2) in the LF band (Bari et al., 2018); (ii) averaging
the transfer function gain in the LF band (Pinna et al., 2017);
(iii) sampling the transfer function gain at the weighted central
frequency of the SAP spectral components dropping in the LF
band (Porta et al., 2000, 2013). These three non-causal markers
were compared to a causal BRS estimate accounting for the
closed loop HP-SAP dynamical interactions and RESP influences
(Baselli et al., 1994; Porta et al., 2013). Each technique was tested
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in patients scheduled for CABG before and after the induction of
propofol general anesthesia.
MATERIALS AND METHODS
Non-causal Open Loop Assessment of
BRS in the Frequency Domain
The non-causal approach is based on the estimation of the
traditional input-output relation via the cross-spectrum between
two series (Saul et al., 1991; Pinna et al., 2002). Being based on
the cross-spectrum, this is an open loop approach that hides
the closed loop structure of the interactions (Porta et al., 2002).
Cross-spectrum was estimated through a parametric approach
based on the computation of the coefficients of the bivariate
autoregressive model assessed over HP and SAP (Porta et al.,
2000). The model order was fixed to 10. The coefficients of the
model were identified through least squares approach (Baselli
et al., 1997). The transfer function was estimated as the ratio
of the cross-spectrum computed from SAP to HP to the power
spectrum of SAP. The BRS function was computed in the
frequency domain as the modulus of the transfer function in
the LF band, namely from 0.04 to 0.15 Hz (Task Force of the
European Society of Cardiology, and the North American Society
of Pacing and Electrophysiology, 1996). The squared HP-SAP
coherence K2 was computed as the ratio between the squared
modulus of the HP-SAP cross-spectrum divided by the product
of the two spectra of HP and SAP. This function was labeled as
K2 and ranged between 0 and 1, with 0 indicates null correlation
and 1 maximum correlation.
Strategies to Derive the BRS Marker
From the BRS Function
A single BRS value was derived from the BRS function according
to three different strategies. The first strategy (Figures 1A,D),
denoted as the MAX strategy, computed the BRS marker as the
sampling of the BRS function at the maximum of the K2 in LF
band (Bari et al., 2018). The index was indicated as BRSMAX.
The correspondent peak of the K2 was also stored and labeled
as K2MAX. The second approach took the average of the BRS
function in the LF band (Figures 1B,E) (Pinna et al., 2017).
This approach will be referred to as the AVG strategy. The index
was indicated as BRSAVG. Similarly, K2 was averaged in the LF
band and this average was indicated as K2AVG. The third strategy
assessed BRS (Figures 1C,F) as the sampling of the BRS function
at the weighted central frequency (WCF) of SAP, namely at the
average central frequency of spectral components of SAP series
dropping in the LF band computed using their power as weights
(Porta et al., 2000, 2013). The spectral decomposition technique
was applied to obtain SAP spectral components, their central
frequency and power (Baselli et al., 1997). This approach will be
referred to as the WCF strategy. The BRS marker was indicated
as BRSWCF. K2 was sampled at WCF as well and the value was
indicated as K2WCF. K2 markers were dimensionless, while BRS
indexes were expressed in ms·mmHg−1. It is worth noting that,
while MAX and AVG approaches can be applied in the 100% of
the subjects in any experimental condition, the WCF one can be
performed only whether at least one spectral component with
central frequency dropping in the LF band was detected in the
power spectrum of SAP variability series. By definition, BRSMAX,
BRSAVG and BRSWCF were larger than 0.
Causal Closed Loop Assessment of BRS
The gains along the two arms of the HP-SAP closed loop control
(i.e., the baroreflex feedback pathway from SAP to HP and the
mechanical feedforward arm from HP to SAP) were estimated
according to a causal linear trivariate model describing the
HP-SAP dynamical interactions and considering RESP as an
exogenous input acting on both series (Baselli et al., 1994; Porta
et al., 2000). In particular, the current HP and SAP were described
according to an autoregressive model with exogenous input that
combines previous samples of the same series with previous, and
eventually present, values of the other series present in the set
formed by HP, SAP, RESP with a sample of a white random
noise. Being the model structure fully exploited to disentangle the
baroreflex feedback pathway from the mechanical feedforward
one and considering the directional structure of the model blocks
(i.e., the output depends on past, and eventually present, values
of the input), the approach is in closed loop and causal. Since
RESP was considered exogenous to both HP and SAP time series,
RESP dynamic was modeled via the linear combination of its past
values plus a sample of a random white noise. All regressions
had the same order optimized in the range from 4 to 14 via the
Akaike information criterion for multivariate processes. Further
details on the procedures followed to estimate the coefficients
of the linear regressions and optimization of the model order
can be found in Baselli et al. (1997), Porta et al. (2013). The
BR gain was computed by feeding the block representing the
dynamical relation from SAP to HP with an artificial SAP
ramp of unit slope simulating a SAP rise. The slope of the
corresponding HP response computed over the first 15 samples
was then taken as an estimate of BRS, labeled as BRSSAP→HP,
and expressed in ms·mmHg−1. The gain of the mechanical
feedforward pathway was estimated as the first coefficient of the
dynamical relation from HP to SAP. It was labeled as aHP→SAP(1)
and expressed in mmHg·s−1. Both BRSSAP→HP and aHP→SAP(1)
can be smaller than 0.
Experimental Protocol
One-hundred twenty-nine patients (67 ± 10 years, age from
43 to 86 years, 112 males) scheduled for elective, or urgent,
CABG surgery at the Department of Cardiothoracic and Vascular
Anesthesia and Intensive Care of the IRCCS Policlinico San
Donato, San Donato Milanese, Milan, Italy, were enrolled for this
study. The study was performed in keeping with the Declaration
of Helsinki for research studies involving humans and, before
participating, subjects signed a written informed consent. The
study was approved by the ethical committee in charge at the
IRCCS Policlinico San Donato.
Inclusion criteria were sinus rhythm, age over 18 years,
absence of previous kidney dysfunction and of autonomic
nervous system pathology. Electrocardiogram (ECG) and
invasive AP, measured at the radial artery, were acquired directly
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FIGURE 1 | The line graphs show examples of computation of the BRS markers. They are derived from HP and SAP series recorded from the same subject during
PRE. The first strategy samples the BRS function (A) in the LF band at the maximum of K2 (D). The sampling of the BRS function and K2 is marked with a solid
circle in both (A) and (D). The second strategy averages the BRS function in the LF band. The average of the BRS and the average of K2 is indicated with a solid
circle in (B) and (E). The third strategy samples the BRS function (C) at the WCF of the spectral components of SAP power spectral density PSDSAP (F, solid line)
detected in LF band. The sampling of the BRS function (C) and K2 (F, dashed line) is marked with a solid circle. The frequency in correspondence of the sampling
was indicated as vertical dotted lines as well as the inferior and superior limits of the LF band.
from patient’s monitor with an analog-to-digital board (National
Instruments, Austin, TX, United States) connected to a laptop
for 10 min before (PRE) and after (POST) the induction of
general anesthesia performed with propofol and remifentanil.
About 1 h before the first acquisition, patients were treated with
an intramuscular injection of 0.5 mg of atropine and 100 µg of
fentanyl. Anesthesia was induced with an intravenous bolus of
1.5 mg·kg−1 of propofol and 0.2 µg·kg−1·min−1 of remifentanil
according to the standard practice of our institute and was
then maintained by infusion at a rate of 3 mg·kg−1·h−1 and
from 0.05 to 0.5 µg·kg−1·min−1 respectively. Subjects breathed
spontaneously during PRE and were mechanically ventilated at a
rate from 12 to 16 breaths per minute during POST, inhaling a
mixture of 1:1 of oxygen and air. Patients were followed during
their stay in ICU after CABG surgery and their serum creatinine
level was monitored. AKD was defined as any postoperative
increase of serum creatinine level from preoperative values in the
first 48 h after surgery (Ranucci et al., 2017). Patients were then
divided in two groups, defined as AKD (n = 29, age 68.7 ± 10.6,
24 males) and noAKD (n = 100, age 66.0 ± 9.4, 88 males),
according to whether the occurrence of AKD after CABG surgery
was observed or not.
Beat-to-Beat Series Extraction and Time
Domain Indexes
From ECG and AP signals, beat-to-beat variability series were
extracted. HP was measured as the temporal distance between
two R-wave peaks on the ECG. SAP was taken as the maximum
of AP inside the HP and diastolic AP (DAP) as the minimum of
AP following SAP. The amplitude of the first QRS complex (from
baseline to apex) was utilized as an ECG-derived RESP series
(Porta et al., 1998). Series lasting 250 beats were extracted during
PRE and POST and they were manually inspected and corrected
in case of missing beats or misdetections. The effect of ectopic
beats was limited via linear interpolation using the most adjacent
values of HP, SAP and DAP unaffected by ectopies. Corrections
never exceeded 5% of total beats utilized for the analysis. Time
domain indexes as mean and variance of HP, SAP and DAP
were calculated. They were labeled as µHP, σ2HP, µSAP, σ2SAP,
µDAP and σ2DAP, and expressed respectively in ms, ms2, mmHg,
mmHg2, mmHg, mmHg2.
Statistical Analysis
Unpaired t-test, or Mann–Whitney rank sum test when
appropriate, was applied over demographic and clinical variables
to test their difference between noAKD and AKD groups.
χ2 test was used in case of dichotomous variables. Two-way
repeated measures analysis of variance (one factor repetition,
Holm–Sidak test for multiple comparisons) was performed over
cardiovascular control parameters to assess differences between
groups (i.e., noAKD and AKD) assigned the experimental
condition (i.e., PRE or POST) and between conditions assigned
the group of individuals.
In the multivariate logistic regression model built over
demographic and clinical factors capable of discriminating
the two groups with p < 0.1 the cardiovascular variability
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markers were introduced one by one. Regression coefficient,
odds ratio, 95% confidence interval and type I error probability
p of the multivariate logistic regression model were evaluated
to assess the degree of association of cardiovascular variability
markers with the outcome accounting for the demographic and
clinical factors. For the variability markers that remained
associated with the outcome with p < 0.05, a receiver
operating characteristic (ROC) curve was calculated at
the univariate level and the area under the ROC curve
(AUC) was assessed. The best combination of sensitivity
and specificity was found according to the Youden index for
each variability parameter remaining significantly associated
with the outcome and the negative predictive value (NPV)
and positive predictive value (PPV) were consequently
assessed. Then, a ROC curve was built using all the clinical
parameters that remained associated with the outcome
with p < 0.05 alone or in combination with every single
cardiovascular variability marker that remained associated
with the outcome. The performance of the discrimination
between AKD and noAKD group of the multivariate logistic
regression models was evaluated via the AUC. Statistical
analyses were carried out using commercial statistical software
(Sigmaplot version 14.0, Systat, Inc., Chicago, IL, United States
and IBM SPSS Statistics version 22.0, IBM, Armonk, NY,
United States). A p < 0.05 was deemed as significant for
all the analyses.
RESULTS
Table 1 summarizes clinical and demographic parameters of
noAKD and AKD subjects. Only hematocrit (HTC) was lower in
patients developing AKD post-surgery. The preoperative serum
creatinine level was not different between groups but the type
I error probability p was below the value set to include this
parameter in the multivariate logistic regression model (i.e., 0.1).
As a consequence of the outcome, patients developing AKD had a
longer mechanical ventilation time and stay in intensive care unit.
Table 2 shows results of time domain parameters assessed
in noAKD and AKD subjects during PRE and POST. The
cardiovascular control depression induced by general anesthesia
was evident. In fact, an increase of µHP during POST could
be observed in both noAKD and AKD groups as well as a
concomitant reduction of µSAP, µDAP and σ2HP. σ2SAP was
significantly reduced in POST only in noAKDs. Only σ2HP
and σ2SAP were able to separate AKD from noAKD group:
indeed, during PRE σ2HP and σ2SAP were lower in AKDs than
noAKDs. σ2DAP was similar in both groups irrespective of the
experimental condition.
As expected, K2 and BRS markers were computed in 100%
of the subjects via AVG and MAX strategies. Conversely, it was
possible to compute K2 and BRS markers with the WCF strategy
in the 96% of noAKD subjects during PRE, 99% of noAKDs
during POST, 93.1% of AKDs during PRE and 100% of AKDs
during POST. BRSSAP→HP and aHP→SAP(1) were computed in
100% of the subjects irrespective of the group.
Table 3 shows the results of K2 assessed between HP and
SAP according to the different strategies (i.e., MAX, AVG, and
WCF). All K2 markers were reduced during POST compared
to PRE. Reduction was significant regardless of the group with
the notable exception of K2AVG that diminished significantly
only in noAKDs. None of the K2 markers was able to
differentiate the two groups.
Box-and-whisker plots of Figure 2 show the BRS values
as a function of the experimental condition (i.e., PRE and
POST) in noAKDs (white boxes) and AKDs (gray boxes). The
BRS estimates are computed via the MAX (Figure 2A), AVG
(Figure 2B), and WCF (Figure 2C) strategies. BRSMAX, BRSAVG
and BRSWCF were significantly reduced during POST in AKD
subjects compared to noAKD ones, while no between-group
differences were observed during PRE. BRSMAX and BRSAVG
were not affected by propofol anesthesia regardless of the group
(i.e., noAKD or AKD). Conversely, BRSWCF decreased during
POST in AKD group, while it was not influenced by propofol
anesthesia in noAKDs.
Figure 3 has the same structure of Figure 2 but it shows
results of BRSSAP→HP (Figure 3A) and aHP→SAP(1) (Figure 3B).
TABLE 1 | Clinical and demographic markers in noAKD and AKD subjects.
Marker noAKD (n = 100) AKD (n = 29) p
Age [years] 66.0 ± 9.4 68.7 ± 10.6 0.21
Gender [male] 88 (88) 24 (83) 0.32
Weight [kg] 78.6 ± 14.9 78.1 ± 17.4 0.88
BMI [kg·m−2] 28.2 ± 14.7 27.2 ± 4.94 0.70
Congestive heart failure 3 (3) 2 (7) 0.31
Recent myocardial infarction 14 (14) 4 (14) 0.55
LVEF [%] 52.8 ± 11.9 52 ± 10.3 0.75
Diabetes 29 (29) 11 (38) 0.24
COPD 7 (7) 3 (10) 0.40
Serum creatinine [mg·dl−1] 1.0 ± 0.3 1.2 ± 0.87 0.08
Hypertension 62 (62) 22 (76) 0.12
Previous cerebrovascular accident 7 (7) 2 (7) 0.67
HCT [%] 39.6 ± 3.8 36.4 ± 4.6 <0.001
Catecholamine administration 14 (14) 3 (33) 0.15
ACE inhibitors 29 (29) 11 (38) 0.24
Beta-blockers 57 (57) 17 (59) 0.53
Calcium antagonists 7 (7) 0 (0) 0.16
Amiodarone 8 (8) 4 (14) 0.27
Combined intervention 6 (6) 2 (7) 0.57
Logistic EuroSCORE 1.8 ± 1.8 2.3 ± 1.2 0.12
CPB time [minutes] 63.3 ± 20.7 66.8 ± 26.8 0.45
Nadir temperature on CPB [◦C] 32.9 ± 0.8 32.9 ± 0.9 0.98
Mechanical ventilation time [hours] 12.1 ± 1.6 17.8 ± 11.5 <0.001
ICU stay [days] 2.0 ± 1.6 3.0 ± 2.2 0.001
Hospital stay [days] 7.7 ± 2.5 8.0 ± 3.2 0.61
BMI, body mass index; LVEF, left ventricular ejection fraction; COPD, chronic
obstructive pulmonary disease; HCT, hematocrit; ACE, angiotensin converting
enzyme; EuroSCORE, European System for Cardiac Operative Risk Evaluation;
CPB, cardiopulmonary bypass; ICU, intensive care unit; p, type I error probability.
Continuous data are presented as mean ± standard deviation and categorical data
as number (percentage).
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TABLE 2 | Time domain parameters in noAKD and AKD patients during PRE and POST.
Marker PRE POST
noAKD AKD noAKD AKD
µHP [ms] 936.7 ± 147.0 922 ± 124.0 1112.2 ± 152.7∗ 1091.0 ± 216.9∗
σ2HP [ms2] 1709.9 ± 1473.4 1016.8 ± 1110.7§ 714.9 ± 996.4∗ 333.5 ± 289.8∗
µSAP [mmHg] 160.2 ± 27.7 170.4 ± 30.5 108.1 ± 18.6∗ 109.0 ± 25.7∗
σ2SAP [mmHg2] 34.5 ± 49.3 20.5 ± 12.4§ 17.3 ± 19.3∗ 12.1 ± 7.4
µDAP [mmHg] 78.0 ± 17.6 72.6 ± 10.4 61.5 ± 9.9∗ 59.7 ± 10.5∗
σ2DAP [mmHg2] 64.7 ± 181.9 25.6 ± 80.7 67.8 ± 251.7 8.5 ± 9.4
HP, heart period; AP, arterial pressure; SAP, systolic AP; DAP, diastolic AP; µHP, HP mean; σ 2HP, HP variance; µSAP, SAP mean; σ 2SAP, SAP variance; µDAP, DAP mean;
σ 2DAP, DAP variance. The symbol ∗ indicates p < 0.05 versus PRE within the same group (i.e., noAKD or AKD). The symbol § indicates p < 0.05 versus noAKD within
the same experimental condition (i.e., PRE or POST).
TABLE 3 | K2 values computed according to the three different strategies.
Marker PRE POST
noAKD AKD noAKD AKD
K2MAX 0.56 ± 0.22 0.56 ± 0.23 0.33 ± 0.19∗ 0.28 ± 0.16∗
K2WCF 0.36 ± 0.39 0.30 ± 0.42 0.17 ± 0.16∗ 0.12 ± 0.10∗
K2AVG 0.35 ± 0.20 0.36 ± 0.19 0.16 ± 0.11∗ 0.12 ± 0.08
HP, heart period; SAP, systolic arterial pressure; LF, low frequency; K2, squared
coherence between HP and SAP; K2MAX, maximum K2 in the LF band; K2AVG,
averaged K2 in the LF band; K2WCF, K2 sampled at the weighted central
frequency of the SAP spectral components in the LF band. The symbol ∗ indicates
p < 0.05 versus PRE.
BRSSAP→HP was reduced during POST with respect to PRE
regardless of the group (i.e., noAKD or AKD). Moreover, after
the induction of anesthesia BRSSAP→HP in AKDs was lower
than in noAKDs. The effect of the anesthesia was evident over
aHP→SAP(1): indeed, it became less negative during POST in
both groups. However, aHP→SAP(1) was not able to differentiate
noAKDs from AKDs regardless of the experimental condition
(i.e., PRE or POST).
All the indexes exhibiting between-group differences at a
univariate level (i.e., σ2HP and σ2SAP during PRE, BRSMAX,
BRSAVG, BRSWCF, and BRSSAP→HP during POST) entered a
multivariate logistic regression model accounting for clinical
and demographic factors resulting different between noAKD
and AKD groups with a p < 0.1 (i.e., HTC and preoperative
serum creatinine level). Only BRS indexes, regardless of
the strategy used to calculate them, remained significantly
associated with the outcome while time domain indexes
did not. Moreover, when BRS markers were examined in
combination with HTC and preoperative serum creatinine level,
only HTC remained associated to the outcome. Regression
coefficient, odds ratio, 95% confidence interval and type I
error probability p of the multivariate logistic regression
models are shown in Table 4 as well as AUCs of the
ROC curves. It can be observed that the combination of
clinical parameters (i.e., HTC) with the BRS improves the
predictive power of AKD as stressed by the increase of
AUC compared to the model accounting for the sole HTC.
However, the difference between the AUC computed over HTC
and that computed by combining HTC with BRS markers is
limited. It is worth noting that the model combining HTC
with BRSAVG during POST achieved the highest AUC at
multivariate level. Figure 4 shows the superposition of the
ROC curves assessed from the multivariate logistic regression
models built using only HTC (blue line) and by combining
HTC with BRSSAP→HP during POST (yellow line), HTC
and BRSWCF during POST (green line), HTC with BRSAVG
during POST (red line), and HTC with BRSMAX during
POST (black line).
Receiver operating characteristic curves were also calculated
using solely BRS markers able to distinguish AKD and noAKD
groups (i.e., BRSMAX, BRSAVG, BRSWCF, and BRSSAP→HP).
The AUC of ROC curves relevant to BRSMAX, BRSAVG,
BRSWCF, and BRSSAP→HP during POST were 0.641, 0.662,
0.658, and 0.671 respectively. The cutoff value for each BRS
marker was calculated according to the Youden’s index, and
the corresponding sensitivity, specificity, PPV and NPV were
computed and reported in Table 5. It can be observed
that BRSSAP→HP reported the highest AUC assessed at the
univariate level with the highest specificity (i.e., 79%) and
PPV (i.e., 41.7%) compared to BRSMAX, BRSAVG, and BRSWCF.
The improved specificity and PPV of BRSSAP→HP were
reached at the cost of a reduced sensitivity (i.e., 51.7%)
and NPV (i.e., 84.9%) with respect to BRSMAX, BRSAVG,
and BRSWCF.
DISCUSSION
The main findings of this work can be summarized as follows:
(i) propofol general anesthesia depresses autonomic function and
cardiovascular control; (ii) the reduction of BRS during propofol
general anesthesia is more evidently detected using causal than
non-causal BRS estimates; (iii) time domain markers are weakly
associated with AKD; (iv) BRS markers can separate AKD from
noAKD individuals regardless of the computational strategy;
(v) BRS assessed after propofol general anesthesia induction
is reduced in subjects developing AKD; (vi) both non-causal
and causal BRS markers remain associated to AKD even after
accounting for clinical and demographic confounding factors;
Frontiers in Physiology | www.frontiersin.org 6 October 2019 | Volume 10 | Article 1319
fphys-10-01319 October 17, 2019 Time: 18:24 # 7
Bari et al. Baroreflex and Post-CABG Acute Kidney Dysfunction
FIGURE 2 | The box-and-whisker graphs show BRSMAX (A), BRSAVG (B), and BRSWCF (C) as a function of the experimental condition (i.e., PRE and POST) in
noAKD (white boxes) and AKD (gray boxes) individuals. Box height represents the interquartile range, median is marked with a solid line and whiskers denote the 5th
and 95th percentile. The symbol ∗ indicates a significant change between experimental conditions (i.e., PRE and POST) within the same group (i.e., noAKD or AKD),
while the symbol § indicates a significant difference between groups within the same experimental condition with p < 0.05.
FIGURE 3 | The box-and-whisker graphs show BRSSAP→HP (A) and aHP→SAP(1) (B) as a function of the experimental condition (i.e., PRE and POST) in noAKD
(white boxes) and AKD (gray boxes) individuals. Box height represents the interquartile range, median is marked with a solid line and whiskers denote the 5th and
95th percentile. The dotted lines mark the zero value. The symbol ∗ indicates a significant change between experimental conditions (i.e., PRE and POST) within the
same group (i.e., noAKD or AKD), while the symbol § indicates a significant difference between groups within the same experimental condition with p < 0.05.
(vii) performances of non-causal and causal BRS indexes in
stratifying the risk of AKD after CABG were similar.
Autonomic Function and Cardiovascular
Control Are Depressed During Propofol
General Anesthesia
Propofol-based general anesthesia is known to depress
autonomic function and cardiovascular control (Boer et al.,
1990; Ebert et al., 1992; Sellgren et al., 1994; Hidaka et al., 2005;
Sato et al., 2005; El Beheiry and Mak, 2013; Porta et al., 2013)
leading to bradycardia (Tramer et al., 1997) and hypotension
(Au et al., 2016). This result is confirmed in this study. Indeed,
the mean of HP increased and mean of both SAP and DAP
decreased. Moreover, the decrease of HP variance suggests a
depression of autonomic control (Pomeranz et al., 1985). The
effect of propofol general anesthesia was less strong on variance
of SAP than HP and that on DAP variance was even weaker.
The effect of propofol anesthesia was more evident over causal
than non-causal BRS markers: indeed, the causal BRS marker
was the sole index able to indicate the decrease of BRS in both
AKDs and noAKDs during POST. The better performance of
the causal closed loop BRS estimate compared to non-causal
BRS markers in detecting the impairment of the BR control
during propofol anesthesia was first suggested over a smaller
group of CABG patients in Porta et al. (2013). The improved
performance is likely to be due to the ability of the causal closed
loop approach to account for the non-baroreflex-mediated origin
of part of the HP variability in the LF band (Preiss and Polosa,
1974; Baselli et al., 1994) and for the anticausal effects related to
the active presence of mechanical feedforward pathway (Porta
et al., 2013). Also the migration of the gain of the mechanical
feedforward arm toward 0 during propofol anesthesia, originally
observed in Porta et al. (2013) and interpreted along with the
BRS decrease as an indication of the depression of the overall
HP-SAP control loop, was confirmed in the present study. The
reduction of the impact of HP variability on SAP changes along
the mechanical feedforward pathway is the likely consequence of
vasodilatation and reduced left ventricular contractility induced
by propofol anesthesia (Porta et al., 2013). The overall depression
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of the cardiovascular control in response to propofol anesthesia
was suggested even by the significant decrease of K2 during
POST regardless of the method utilized for the computation
of K2 marker.
Time Domain Markers Separate AKDs
From noAKDs but They Are Not
Associated With AKD After Accounting
for Clinical and Demographic Factors
Few markers in the time domain were able to separate
AKD and noAKD groups during PRE (i.e., σ2HP and σ2SAP).
Since σ2HP is directly linked to the amplitude of both vagal
and sympathetic outflow modulations directed to the heart
(Pomeranz et al., 1985; Montano et al., 1994), while σ2SAP
raises with the relevance of sympathetic outflow modulations
directed to the vessels (Pagani et al., 1997; Cooke et al., 1999;
Marchi et al., 2016a), it can be hypothesized that autonomic
regulation could play a role in AKD development. Conversely,
none of the time domain parameters during POST was able to
differentiate AKD from noAKD group and this limited ability
can be taken again a hallmark of the autonomic function
depression following propofol general anesthesia. However,
when σ2HP and σ2SAP during PRE were added one by
one to clinical and demographic markers featuring the best
performance in separating AKDs from noAKDs (i.e., HTC and
TABLE 4 | Results of multivariate logistic regression analysis for AKD prediction.
Parameter Regression
coefficient
Odds ratio 95%
confidence
interval
p AUC
BRSMAX during
POST
−0.118 0.889 0.798–0.991 0.034 0.741
HCT −0.196 0.822 0.731–0.925 0.001
Constant 6.870 963.067 0.002
BRSAVG during
POST
−0.188 0.829 0.697–0.984 0.032 0.747
HCT −0.194 0.823 0.732–0.926 0.001
Constant 6.823 918.982 0.003
BRSWCF during
POST
−0.154 0.857 0.736–0.998 0.048 0.742
HCT −0.203 0.817 0.725–0.920 0.001
Constant 7.017 531.34 0.002
BRSSAP→HP
during POST
−0.345 0.708 0.529–0.948 0.020 0.731
HCT −0.184 0.832 0.741–0.934 0.002
Constant 5.687 295.054 0.010
HCT −0.200 0.819 0.731–0.918 0.001 0.690
Constant 6.344 568.82 0.004
BRS, baroreflex sensitivity; HP, heart period; SAP, systolic arterial pressure; LF, low
frequency; BRSMAX, BRS obtained by sampling the transfer function gain between
HP and SAP at the maximum of HP-SAP squared coherence in LF band; BRSAVG,
BRS obtained as the average of the transfer function gain between HP and SAP in
LF band; BRSWCF, BRS obtained by sampling the transfer function gain between
HP and SAP at the weighted central frequency of the SAP spectral components in
LF band; BRSSAP→HP, causal closed loop BRS; POST, after anesthesia induction;
HCT, hematocrit; AUC, area under the receiver operating characteristic curve.
FIGURE 4 | The multiple line plot shows the ROC curves obtained from the
multivariate logistic regression models built using only HTC (blue line) and by
combining HTC with BRSSAP→HP during POST (yellow line), HTC and
BRSWCF during POST (green line), HTC with BRSAVG during POST (red line),
and HTC with BRSMAX during POST (black line).
serum creatinine level), time domain markers did not provide
complementary information, thus supporting the concept that
AKD is weakly linked to the magnitude of autonomic activity
and/or modulation. This disappointing finding could be the
consequence of the unspecific characteristic of these two markers,
thus prompting for the exploitation of cardiovascular control
indexes that are much more specifically linked to regulatory
reflexes such as the BR.
BRS Is Lower in AKDs During POST and
the BRS Association With AKD Remains
After Accounting for Clinical and
Demographic Factors
Both non-causal and causal BRS estimates were able to
distinguish AKD and noAKD groups while markers measuring
the mere association between HP and SAP variability series
(i.e., K2 indexes) and the gain of the mechanical feedforward
pathway were useless. Remarkably, all BRS indexes remained
associated to the adverse outcome even when combined with
clinical and demographic parameters that were detected to be
significantly associated to AKD, thus confirming the relevance
of the association between BRS and AKD (Ranucci et al.,
2017). Remarkably, this association was confirmed in this
study using an additional class of methods for BRS estimation,
namely the causal closed loop method. More specifically, we
found that BRS was lower in patients who developed AKD
after CABG, thus suggesting that a more active BR control
is protective against AKD, while a depressed BR regulation
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TABLE 5 | Results of logistic regression analysis for AKD prediction.
Parameter cutoff [ms·mmHg−1] sensitivity specificity PPV NPV AUC
BRSMAX during POST 7.73 93.1% 36.4% 29.8% 94.8% 0.641
BRSAVG during POST 3.17 82.8% 53.5% 34.1% 91.5% 0.662
BRSWCF during POST 4.82 93.1% 28.5% 29.5% 94.6% 0.658
BRSSAP→HP during POST −0.59 51.7% 79.0% 41.7% 84.9% 0.671
BRS, baroreflex sensitivity; HP, heart period; SAP, systolic arterial pressure; LF, low frequency; BRSMAX, BRS obtained by sampling the transfer function gain between
HP and SAP at the maximum of HP-SAP squared coherence in LF band; BRSAVG, BRS obtained as the average of the transfer function gain between HP and SAP in
LF band; BRSWCF, BRS obtained by sampling the transfer function gain between HP and SAP at the weighted central frequency of the SAP spectral components in
LF band; BRSSAP→HP, causal closed loop BRS; POST, after anesthesia induction; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the
receiver operating characteristic curve.
should be considered a risk factor for the development of AKD.
The association between low BRS values and AKD could be
the consequence of an insufficient BR response to hypotension
and hypoperfusion situations that might be occurred during
CABG surgery (Mangano et al., 1998; Provenchere et al., 2003;
Pavlov and Tracey, 2012). However, given the link of a low
BRS with vagal withdrawal and sympathetic activation (Cooke
et al., 1999; Marchi et al., 2016b; De Maria et al., 2018), the
association between a depressed BRS value and AKD could
be the result of the abnormal reaction to inflammation and
anomalous levels of oxidative stress favored by a limited vagal
control and a high sympathetic drive (Pavlov and Tracey,
2012; Inoue et al., 2016a,b). Our interpretation of the findings
privileges the causal pathway that an impaired BR causes AKD.
This interpretation is supported by the lower BRS observed
during POST well before the AKD development and by the
observation that an impaired autonomic control is a risk factor
for chronic kidney disease (Brotman et al., 2010). However,
the reverse pathway, namely an incoming, or manifest, AKD
could determine a BR impairment, cannot be dismissed. Indeed,
previous studies have shown how the renal impairment can be
an independent risk factor for cardiovascular events and heart
failure (Omar and Zedan, 2013) and that an increased afferent
renal sympathetic activity from impaired kidneys is critically
involved in the pathogenesis of sympathetic hyperactivity
(Blankestijn and Joles, 2012).
Remarkably, the association of BRS markers with the outcome
was observed during POST, while it was not visible during
PRE. This result might be at first sight quite surprising given
the well-known depression of autonomic control and baroreflex
regulation during propofol general anesthesia (Boer et al., 1990;
Ebert et al., 1992; Sellgren et al., 1994; Hidaka et al., 2005;
Sato et al., 2005; El Beheiry and Mak, 2013; Porta et al., 2013)
confirmed even by the present study. However, on the one
hand, baroreflex regulation is depressed but not absent (Porta
et al., 2013) and, on the other hand, hemodynamic instability
observed during CABG surgery, brief periods of inadequate
delivery of oxygen to the tissues (Toner et al., 2016), and
episodes of hypotension and hypoperfusion (Ranucci et al.,
2017) might have stimulated more importantly the residual BR
control during POST than PRE. Also mechanical ventilation,
profoundly influencing venous return and stroke volume, might
have contributed to solicit the residual BR at frequencies slower
than the ventilatory one.
We point out that the cutoff values of BRS assessed
according to the Youden’s index varies with the strategy
for BRS computation, being equal to 7.73, 3.17, 4.82, and
−0.59 ms·mmHg−1 for BRSMAX, BRSAVG, BRSWCF, and
BRSSAP→HP respectively. The results relevant to non-causal
BRS estimates are in agreement with the different cutoff values
of BRS utilized to predict adverse events present in literature
(La Rovere et al., 1998; Gouveia et al., 2015; Toner et al.,
2016; Ranucci et al., 2017; Pinna et al., 2017). Cutoff values
depend on the method exploited for BRS estimation (Pinna
et al., 2017), type of pathology (La Rovere et al., 1998; Gouveia
et al., 2015) and endpoint of the analysis (Toner et al., 2016;
Ranucci et al., 2017). This study suggests that even within the
same class of methods for the BRS estimation (i.e., the non-
causal class in the frequency domain) cutoff values might vary
importantly according to the strategy followed to derive the
final BRS values utilized to typify the patient. Since BRSSAP→HP
was computed according to a completely different method (i.e.,
the causal closed loop technique), it is not surprising that the
cutoff value of BRSSAP→HP was significantly different from those
of the non-causal markers. Indeed, it was negative according
to the possibility given by its definition computing the slope
of the HP response to an artificial SAP rise (Baselli et al.,
1994). A negative BRSSAP→HP implies that, instead of having
a bradycardic response to a SAP rise, a tachycardic reaction
is observed. This result provides a new perspective on the BR
control in CABG patients: indeed, the patients most at risk
of developing AKD after CABG are not simply those who
have the most depressed BR control but those who exhibit an
antiparallel HP response to SAP variations. An additional factor
that might increase the variability of the cutoff is the experimental
condition during which the signals were recorded. For example,
BRS estimates computed in this study were useless in separating
AKD from noAKD individuals when evaluated during PRE.
These considerations stress the need for a standardization of the
BRS assessment to favor future clinical applications especially
whether BRS methods based on spontaneous variability will
be exploited. However, roughly speaking about non-causal
frequency domain BRS markers, we confirmed that a cutoff value
of about 3 ms·mmHg−1 can be utilized as a first attempt to make
prediction of adverse outcomes in clinical context where BRS
estimates are found to be significantly associated to the event (La
Rovere et al., 1998). However, this value does not hold for causal
closed loop BRS estimates.
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Comparison of the Performances of
Non-causal and Causal BRS Estimates in
Stratifying the Risk of AKD in CABG
Patients
The present study originally compares the performance of non-
causal and causal BRS markers in stratifying the risk of AKD
after CABG. Performances were similar regardless of the class
of method (i.e., non-causal or causal class) and within the non-
causal class irrespective of the strategy followed to derive a
unique index from the transfer function gain in LF band. It
can be observed that the BRSAVG is slightly superior in terms
of AUC at multivariate level (i.e., in combination with HTC)
and the presumed superiority of BRSSAP→HP compared to non-
causal BRS indexes, resulting from its more complex model
structure, was evident only at univariate level. The BRSAVG
should be preferred given the simplicity of its computation and
remarkable performance. Indeed, the BRSAVG does not require
the presence of a spectral peak in the LF band in the SAP
series like the BRSWCF , the presence of a K2 peak in the LF
band like the BRSMAX, and the identification of a complex
model structure including RESP like the BRSSAP→HP. This study
confirms the feeling pointed out in Pinna et al. (2017) that in
practical applications the full adherence to the concept of the BR,
undoubtedly provided by the causal closed loop strategy, does
not assure a measurable advantage compared to simpler non-
causal techniques likely due to the complexity of the physiological
interactions and the effect of noise on the final estimate making
alike the performance of all the considered methods.
Limitations of the Study and Future
Developments
A limitation of this study is the impossibility of testing the ability
of BRS in discriminating acute kidney injury (i.e., the increase
of postoperative creatinine of more than 50% with respect to
preoperative level), that is a more stringent and risky condition
with respect to AKD. This limitation is due to the relatively small
number of patients who developed acute kidney injury in our
database that prevented any reliable association of BRS markers
with this adverse event. The application of the same approach
after the enlargement of the enrolled population would allow us
in the future to test the association of BRS markers with acute
kidney injury as well.
Moreover, in interpreting the results we privilege the
possibility that a reduced BRS could play a role in the post-
surgery development of AKD but the action of the reverse
pathway, implying a potential influence of an incoming AKD
on BR control, cannot be fully dismissed and calls for
additional studies.
CONCLUSION
This work stresses the relevance of computing BRS markers
from spontaneous variability of HP and SAP computed via
causal and non-causal methods to stratify the risk of AKD
after CABG and their complementary information compared
to clinical and demographic factors. Remarkably, the present
study provided cutoff values that are worth being exploited
to identify subjects at risk of AKD after CABG. Moreover,
we conclude that no evident clinical improvement can be
derived from the application of causal BRS markers with
respect to non-causal BRS ones. Future studies should verify
the clinical impact of the application of the provided cutoff
values and should test whether the use of premedications and/or
countermeasures before CABG surgery aiming at increasing
BRS might have a favorable impact on the incidence of
postoperative AKD.
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